Evaluation of the role of second-look surgery in ovarian cancer

Setsuko K Chambers, Joseph T. Chambers, Ernest I. Kohorn, Roberta Lawrence, Peter E. Schwartz

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The role of second-look surgery in the management of patients with ovarian cancer has come under question. One hundred one patients have undergone the operation at Yale University over the last decade. of 67 who had epithelial ovarian cancer, 43% had positive and 57% had negative second-look surgery. Multivariate analysis revealed that stage was a significant prognostic factor with regard to second-look surgery findings, as well as absolute and disease- free survival. We found initial tumor size and results of cytology at second-look surgery to be prognostic factors with regard to survival after a positive second-look surgery. Survival after negative second-look surgery was significantly greater than that after a positive operation. However, no improvement in survival accrued to the group of advanced- stage, platinum-treated patients who underwent second- look surgery, compared with a similar group of patients who were eligible but did not undergo the procedure. We conclude that second-look surgery in epithelial ovarian cancer patients should be limited to experimental protocol situations in which precise measurement of tumor size may be important. In ovarian germ cell malignancies, second look surgery, in the absence of tumor markers, can be justified.

Original languageEnglish (US)
Pages (from-to)404-408
Number of pages5
JournalObstetrics and Gynecology
Volume72
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Second-Look Surgery
Ovarian Neoplasms
Survival
Neoplasms
Tumor Biomarkers
Platinum
Germ Cells
Disease-Free Survival
Cell Biology
Multivariate Analysis

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Chambers, S. K., Chambers, J. T., Kohorn, E. I., Lawrence, R., & Schwartz, P. E. (1988). Evaluation of the role of second-look surgery in ovarian cancer. Obstetrics and Gynecology, 72(3), 404-408.

Evaluation of the role of second-look surgery in ovarian cancer. / Chambers, Setsuko K; Chambers, Joseph T.; Kohorn, Ernest I.; Lawrence, Roberta; Schwartz, Peter E.

In: Obstetrics and Gynecology, Vol. 72, No. 3, 1988, p. 404-408.

Research output: Contribution to journalArticle

Chambers, SK, Chambers, JT, Kohorn, EI, Lawrence, R & Schwartz, PE 1988, 'Evaluation of the role of second-look surgery in ovarian cancer', Obstetrics and Gynecology, vol. 72, no. 3, pp. 404-408.
Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE. Evaluation of the role of second-look surgery in ovarian cancer. Obstetrics and Gynecology. 1988;72(3):404-408.
Chambers, Setsuko K ; Chambers, Joseph T. ; Kohorn, Ernest I. ; Lawrence, Roberta ; Schwartz, Peter E. / Evaluation of the role of second-look surgery in ovarian cancer. In: Obstetrics and Gynecology. 1988 ; Vol. 72, No. 3. pp. 404-408.
@article{95c317a298a34cdbb76bfaba5db36626,
title = "Evaluation of the role of second-look surgery in ovarian cancer",
abstract = "The role of second-look surgery in the management of patients with ovarian cancer has come under question. One hundred one patients have undergone the operation at Yale University over the last decade. of 67 who had epithelial ovarian cancer, 43{\%} had positive and 57{\%} had negative second-look surgery. Multivariate analysis revealed that stage was a significant prognostic factor with regard to second-look surgery findings, as well as absolute and disease- free survival. We found initial tumor size and results of cytology at second-look surgery to be prognostic factors with regard to survival after a positive second-look surgery. Survival after negative second-look surgery was significantly greater than that after a positive operation. However, no improvement in survival accrued to the group of advanced- stage, platinum-treated patients who underwent second- look surgery, compared with a similar group of patients who were eligible but did not undergo the procedure. We conclude that second-look surgery in epithelial ovarian cancer patients should be limited to experimental protocol situations in which precise measurement of tumor size may be important. In ovarian germ cell malignancies, second look surgery, in the absence of tumor markers, can be justified.",
author = "Chambers, {Setsuko K} and Chambers, {Joseph T.} and Kohorn, {Ernest I.} and Roberta Lawrence and Schwartz, {Peter E.}",
year = "1988",
language = "English (US)",
volume = "72",
pages = "404--408",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Evaluation of the role of second-look surgery in ovarian cancer

AU - Chambers, Setsuko K

AU - Chambers, Joseph T.

AU - Kohorn, Ernest I.

AU - Lawrence, Roberta

AU - Schwartz, Peter E.

PY - 1988

Y1 - 1988

N2 - The role of second-look surgery in the management of patients with ovarian cancer has come under question. One hundred one patients have undergone the operation at Yale University over the last decade. of 67 who had epithelial ovarian cancer, 43% had positive and 57% had negative second-look surgery. Multivariate analysis revealed that stage was a significant prognostic factor with regard to second-look surgery findings, as well as absolute and disease- free survival. We found initial tumor size and results of cytology at second-look surgery to be prognostic factors with regard to survival after a positive second-look surgery. Survival after negative second-look surgery was significantly greater than that after a positive operation. However, no improvement in survival accrued to the group of advanced- stage, platinum-treated patients who underwent second- look surgery, compared with a similar group of patients who were eligible but did not undergo the procedure. We conclude that second-look surgery in epithelial ovarian cancer patients should be limited to experimental protocol situations in which precise measurement of tumor size may be important. In ovarian germ cell malignancies, second look surgery, in the absence of tumor markers, can be justified.

AB - The role of second-look surgery in the management of patients with ovarian cancer has come under question. One hundred one patients have undergone the operation at Yale University over the last decade. of 67 who had epithelial ovarian cancer, 43% had positive and 57% had negative second-look surgery. Multivariate analysis revealed that stage was a significant prognostic factor with regard to second-look surgery findings, as well as absolute and disease- free survival. We found initial tumor size and results of cytology at second-look surgery to be prognostic factors with regard to survival after a positive second-look surgery. Survival after negative second-look surgery was significantly greater than that after a positive operation. However, no improvement in survival accrued to the group of advanced- stage, platinum-treated patients who underwent second- look surgery, compared with a similar group of patients who were eligible but did not undergo the procedure. We conclude that second-look surgery in epithelial ovarian cancer patients should be limited to experimental protocol situations in which precise measurement of tumor size may be important. In ovarian germ cell malignancies, second look surgery, in the absence of tumor markers, can be justified.

UR - http://www.scopus.com/inward/record.url?scp=0023735252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023735252&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 404

EP - 408

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -